Megan Garlapow, PhD

Use of a dilator and/or engaging in sexual activity after treatment for cervical cancer reduced the risk of vaginal stenosis, but not vaginal dryness or bleeding.

Six-month weight loss up to the time of diagnosis and symptom distress were evaluated to determine their effects on quality of life for patients with esophageal cancer treated with surgery and chemotherapy.

Researchers evaluated the differences in malnutrition status, severity of symptoms, and anorexia-cachexia-related QOL prior to and 3 months following pancreatic cancer surgery.

Cross-sectional survey results demonstrate that fear of cancer recurrence varies across 5 domains in breast cancer survivors.

Researchers investigated the effects of multidisciplinary clinical management of IMDC in patients with NSCLC undergoing treatment with immune checkpoint inhibitors.

A quasi-experimental pilot trial sought to determine if aromatherapy could improve sleep, well-being, and other outcomes in hospitalized patients with cancer.

A large-scale study sought to compare the perspectives of healthcare team members with those of Black/Hispanic patients and White patients to determine potential ways to mitigate disparities.

Metastatic melanoma patients at the highest risk of death are more likely than lower-risk patients to receive immunotherapy near the end of their life.

A 12-week app-based exercise program may reduce depressive symptoms in health care professionals, but adherence to the program may be an obstacle.

A new tool, the weighted toxicity score, evaluates toxicity and enables interpretation of expected benefits vs costs of various cancer therapies.